In addition to the extended studies on cisplatin, p73 also sensitizes p53-null colon cancer cells (HCT 116 p53−/−) to withaferin A (WA), a plant-derived proteasomal inhibitor. This evidence concerns the gene TP53 and malignant colon neoplasm.